<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>JCO Article Insights: Duvelisib in Patients with Relapsed or Refractory PTCL</title>
  <description>In this episode of JCO Article Insights, host Ash Gurumurthi summarizes the article &amp;quot;Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma,&amp;quot; by Mehta-Shah and colleagues. LINK TO FULL TRANSCRIPT </description>
  <author_name>Journal of Clinical Oncology (JCO) Podcast</author_name>
  <author_url>http://sites.libsyn.com/58526</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/42232725/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/00457c/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/42232725</thumbnail_url>
</oembed>
